Safety and Preliminary Efficacy Results of a Novel Mesenchymal Stromal Cell Therapy in Diabetic Kidney Disease: The Multicenter, Randomized, Placebo-Controlled, Phase-1b/2a NEPHSTROM Clinical Trial
Matthew D. Griffin, Giuseppe Remuzzi, Paul Cockwell, Alexander P. Maxwell, Norberto Perico, Piero Ruggenenti, Martino Introna, Andrew Finnerty, Jon Smythe, Willem E. Fibbe, Stephen J. Elliman, Timothy O’Brien (2022). Safety and Preliminary Efficacy Results of a Novel Mesenchymal Stromal Cell Therapy in Diabetic Kidney Disease: The Multicenter, Randomized, Placebo-Controlled, Phase-1b/2a NEPHSTROM Clinical Trial. , 33(11S), DOI: https://doi.org/10.1681/asn.20223311s129a.
